Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat
about
Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis.An update on cancer risk and surveillance in primary sclerosing cholangitis.Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified?Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 mice and human cholangiocarcinoma tumorigenesis
P2860
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat
@en
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
@nl
type
label
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat
@en
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
@nl
prefLabel
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat
@en
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
@nl
P2093
P2860
P356
P1433
P1476
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat
@en
P2093
Giulia Bonato
Luca Fabris
Mario Strazzabosco
P2860
P304
P356
10.1159/000440826
P478
33 Suppl 2
P577
2015-12-07T00:00:00Z